Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethanol/sodium citrate versus heparin catheter lock in hemodialysis
IRCT20231017059748N6Phase 3Recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in chronic kidney disease (CKD) and end-stage kidney disease (ESKD) comparing Ethanol/sodium citrate catheter lock with Heparin catheter lock (2 arms). Primary endpoints: Incidence of catheter-related infection, Incidence of catheter-related thrombosis and 1 more. Started Jun 2026; status: recruiting.
02
Drugs
ethanoltrisodium citrateheparin
03
Conditions
chronic kidney disease (CKD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT20231017059748N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231017059748N6.